Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1310.4000
9.60
(
0.74
%)
NSE
Sep 16, 2025
15:31 PM
28.47% Gain from 52W Low
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
01 Aug 2022
US FDA Observation
1310.40
0.74%
Dr. Reddy`s Laboratories
Results Update:
Dr. Reddy's Laboratories Ltd.
by
SMC online
SMC online
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - September 16, 2025
The Baseline |
16 Sep 2025, 06:08PM
Market closes higher, JSW Infrastructure signs a Rs 740 crore agreement with SMPK
Trendlyne Marketwatch |
16 Sep 2025, 03:55PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021